EC Number   |
Substrates |
Organism |
Products |
Reversibility |
|---|
    1.5.1.20 | (6R)-5,10-methylenetetrahydrofolate + NAD(P)H + H+ |
- |
Thermus thermophilus |
(6S)-5-methyltetrahydrofolate + NAD(P)+ |
- |
r |
| 1.5.1.20 | (6R)-5,10-methylenetetrahydrofolate + NAD(P)H + H+ |
- |
Thermus thermophilus HB8 / ATCC 27634 / DSM 579 |
(6S)-5-methyltetrahydrofolate + NAD(P)+ |
- |
r |
| 1.5.1.20 | (6R,S)-5,10-methylenetetrahydrofolate + ? |
- |
Escherichia coli |
? |
- |
? |
| 1.5.1.20 | (6R,S)-5,10-methylenetetrahydrofolate + ? |
- |
Sus scrofa |
? |
- |
? |
| 1.5.1.20 | (6R,S)-5,10-methylenetetrahydrofolate + ? |
assay at 25°C |
Homo sapiens |
? |
- |
? |
| 1.5.1.20 | 1-pyrroline-5-carboxylate + NADH + H+ |
- |
Sus scrofa |
L-proline + NAD+ |
- |
r |
| 1.5.1.20 | 5,10-methylene-5,6,7,8-tetrahydropteroylpentaglutamate + reduced acceptor |
equilibrium lies far in favor of 5-methyl-5,6,7,8-tetrahydropteroylpentaglutamate formation, pentaglutamate form binds to the same enzyme site as monoglutamate form |
Rattus norvegicus |
(+)-5-methyl-5,6,7,8-tetrahydropteroylpentaglutamate + oxidized acceptor |
menadione as acceptor for 5,10-methylene-5,6,7,8-tetrahydropteroylpentaglutamate formation |
? |
| 1.5.1.20 | 5,10-methylenetetrahydrofolate + acceptor |
- |
Homo sapiens |
5-methyltetrahydrofolate + reduced acceptor |
- |
? |
| 1.5.1.20 | 5,10-methylenetetrahydrofolate + acceptor |
- |
Homo sapiens |
5-methyltetrahydrofolate + reduced acceptor |
- |
ir |
| 1.5.1.20 | 5,10-methylenetetrahydrofolate + FADH2 |
- |
Escherichia coli |
5-methyltetrahydrofolate + FAD |
- |
? |
